Article
Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer.
Cancer biology & therapy - 1 Aug 2011
Gallant Jean-Nicolas, Allen Joshua E, Smith Charles D, Dicker David T, Wang Wenge, Dolloff Nathan G, Navaraj Arunasalam, El-Deiry Wafik S
Abstract excerpt
Although treatments have improved patient prognosis in surgically resectable colorectal cancer, new effective drugs with improved safety profiles are needed to improve the currently poor outcomes of patients with recurrent or metastatic colorectal cancer. Quinacrine, a small molecule anti-malarial agent that has activity in giardiasis, lupus, prion disease, and used as a means of non-surgical sterilization, has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
